TRAIL inhibits HBV replication and expression by down-regulating liver-enriched transcription factors

• Published in: Arab journal of gastroenterology 2020-09, Vol.21 (3), p.169-173
• Main Authors: Li, Juan, Liu, Fan-Wei, Wu, Dong-Bo, Chen, En-Qiang, Chen, Xiang-Jun, Chen, Shou-Chun, Liu, Cong, Zhao, Lian-Shan, Tang, Hong, Zhou, Tao-You
• Format: Article
• Language: English
• Subjects: Hepatitis B virus; HNF4α; PPARα; RXRα; TRAIL
• ISSN: 1687-1979; 2090-2387
• DOI: 10.1016/j.ajg.2020.05.002

[Display omitted] To investigate the role of low-concentration TRAIL on HBV replication and expression. MTT assay was performed to determine the minimum concentrations of TRAIL protein in HepG2 cell apoptosis. HepG2 cells were transfected by HBV replication plasmid pHBV4.1. After the treatment with low concentration of TRAIL, the culture supernatant was collected to detect HBsAg and HBeAg by ELISA. Proteins were extracted from the resulted cells, followed by total RNA and HBV DNA intermediate replication. Southern Blot and Northern Blot were carried out to detect HBV RNA and HBV DNA replication intermediates, respectively. RT-PCR and Western Blot were carried out to detect gene and protein expressions for HNF4α, PPARα, and RXRα, respectively. 50 ng/ml of TRAIL protein led to significant decline on the secretions of HBsAg and HBeAg. Expression levels of HBV RNA and HBV DNA replication intermediates were significantly decreased too. In addition, gene and protein expressions of HNF4α, PPARα and RXRα also dropped, especially for PPARα whose expressions significantly decreased. TRAIL could inhibit HBV replication and expression by downregulating the expressions of liver-enriched transcription factors HNF4α, PPARα, and RXRα.